Literature DB >> 23897337

Prevalence of Dupuytren disease in The Netherlands.

Rosanne Lanting1, Edwin R van den Heuvel, Bram Westerink, Paul M N Werker.   

Abstract

BACKGROUND: Dupuytren disease is a fibroproliferative disease of palmar fascias of the hand. The prevalence of Dupuytren disease and the association with potential risk factors have been the subject of several studies, although there is a paucity of such data from The Netherlands.
METHODS: To study the prevalence of Dupuytren disease, the authors drew a random sample of 1360 individuals, stratified by age, from the northern part of The Netherlands. Of this sample, 763 individuals aged 50 to 89 years participated in this cross-sectional study. The authors examined both hands for signs of Dupuytren disease, and a questionnaire was conducted to identify potential risk factors. The effects of these risk factors were investigated using logistic regression analysis. Additional analyses were performed to develop a logistic prediction model for the prevalence of Dupuytren disease.
RESULTS: The prevalence of Dupuytren disease was 22.1 percent. Nodules and cords were seen in 17.9 percent, and flexion contractures were present in 4.2 percent of the study population. Prevalence increased with age, from 4.9 percent in participants aged 50 to 55 years to 52.6 percent among those aged 76 to 80 years. Men were more often affected than women; 26.4 percent versus 18.6 percent, respectively (p=0.007). Other significant risk factors were previous hand injury, excessive alcohol consumption, familial occurrence of Dupuytren disease, and presence of Ledderhose disease.
CONCLUSIONS: The results show a high prevalence of Dupuytren disease in The Netherlands, particularly the nodular form. Using the developed logistic prediction model, the prevalence of Dupuytren disease can be estimated, based on the presence of significant risk factors. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Entities:  

Mesh:

Year:  2013        PMID: 23897337     DOI: 10.1097/PRS.0b013e3182958a33

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  17 in total

Review 1.  [Epidemiology of Dupuytren's disease].

Authors:  P Hahn
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 2.  [Percutaneous needle aponeurotomy for Dupuytren's contracture].

Authors:  J Oppermann; F Unglaub; L P Müller; S Löw; P Hahn; C K Spies
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

3.  Dupuytren Disease Management Trends: A Survey of Hand Surgeons.

Authors:  Logan Carr; Brett Michelotti; Morgan Brgoch; Randy Hauck; John Ingraham
Journal:  Hand (N Y)       Date:  2018-07-25

4.  The Epidemiology of Dupuytren's Disease in Korea: a Nationwide Population-based Study.

Authors:  Kwang-Hyun Lee; Joo-Hak Kim; Chang-Hun Lee; Sung-Jae Kim; Young-Hoon Jo; Myungsub Lee; Wan-Sun Choi
Journal:  J Korean Med Sci       Date:  2018-06-18       Impact factor: 2.153

5.  Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL).

Authors:  Alexis Descatha; Matthieu Carton; Zakia Mediouni; Christian Dumontier; Yves Roquelaure; Marcel Goldberg; Marie Zins; Annette Leclerc
Journal:  BMJ Open       Date:  2014-01-29       Impact factor: 2.692

6.  Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.

Authors:  Evert-Jan P M Ten Dam; Marike M van Beuge; Ruud A Bank; Paul M N Werker
Journal:  J Cell Commun Signal       Date:  2015-12-03       Impact factor: 5.782

7.  Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.

Authors:  Kerstin Becker; Sabine Siegert; Mohammad Reza Toliat; Juanjiangmeng Du; Ramona Casper; Guido H Dolmans; Paul M Werker; Sigrid Tinschert; Andre Franke; Christian Gieger; Konstantin Strauch; Michael Nothnagel; Peter Nürnberg; Hans Christian Hennies
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

Review 8.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

9.  A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis.

Authors:  Michael Ng; Dipti Thakkar; Lorraine Southam; Paul Werker; Roel Ophoff; Kerstin Becker; Michael Nothnagel; Andre Franke; Peter Nürnberg; Ana Isabel Espirito-Santo; David Izadi; Hans Christian Hennies; Jagdeep Nanchahal; Eleftheria Zeggini; Dominic Furniss
Journal:  Am J Hum Genet       Date:  2017-09-07       Impact factor: 11.025

10.  Examiners' influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease.

Authors:  Jesper Nordenskjöld; Stina Brodén; Isam Atroshi
Journal:  BMC Med Res Methodol       Date:  2018-10-29       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.